Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Hammerman

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
The Annals of Pharmacotherapy|July 31, 2008
Antipsychotics and diabetes: an age-related associationAriel Hammerman, Jacob Dreiher, Shmuel H Klang, et al.
The New England Journal of Medicine|December 8, 2021
BNT162b2 Vaccine Booster and Mortality Due to Covid-19Ronen Arbel, Ariel Hammerman, Ruslan Sergienko, et al.
Breast Cancer (Tokyo, Japan)|November 27, 2024
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohortDaniela Katz, Ilan Feldhamer, Yael Wolff-Sagy, et al.
Nature Medicine|April 25, 2022
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 yearsRonen Arbel, Ruslan Sergienko, Michael Friger, et al.
The New England Journal of Medicine|February 16, 2022
Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19Ariel Hammerman, Ruslan Sergienko, Michael Friger, et al.
The American Journal of Medicine|February 19, 2019
Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial FibrillationRonen Arbel, Ruslan Sergienko, Ariel Hammerman, et al.
Plos One|July 8, 2017
Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational studyMaya Leventer-Roberts, Ariel Hammerman, Ilan Brufman, et al.
Sexually Transmitted Diseases|May 31, 2023
Examining the Patterns of Mpox Vaccine Uptake in a Vulnerable PopulationRoy Zucker, Yael Wolff-Sagy, Noga Ramot, et al.
Harefuah|March 20, 2024
[IMPACT OF CLINICAL PHARMACIST CONSULTATIONS ON RATE OF COMPLICATIONS, RE-HOSPITALIZATIONS AND MORTALITY IN PATIENTS UNDERGOING BARIATRIC SURGERY]Almog Eliyahu Dahan, Arik Dahan, Orly Shimoni, et al.
Heart (British Cardiac Society)|April 12, 2019
Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillationRonen Arbel, Ruslan Sergienko, Ariel Hammerman, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
The Annals of Pharmacotherapy|July 31, 2008
Antipsychotics and diabetes: an age-related associationAriel Hammerman, Jacob Dreiher, Shmuel H Klang, et al.
The New England Journal of Medicine|December 8, 2021
BNT162b2 Vaccine Booster and Mortality Due to Covid-19Ronen Arbel, Ariel Hammerman, Ruslan Sergienko, et al.
Breast Cancer (Tokyo, Japan)|November 27, 2024
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohortDaniela Katz, Ilan Feldhamer, Yael Wolff-Sagy, et al.
Nature Medicine|April 25, 2022
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 yearsRonen Arbel, Ruslan Sergienko, Michael Friger, et al.
The New England Journal of Medicine|February 16, 2022
Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19Ariel Hammerman, Ruslan Sergienko, Michael Friger, et al.
The American Journal of Medicine|February 19, 2019
Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial FibrillationRonen Arbel, Ruslan Sergienko, Ariel Hammerman, et al.
Plos One|July 8, 2017
Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational studyMaya Leventer-Roberts, Ariel Hammerman, Ilan Brufman, et al.
Sexually Transmitted Diseases|May 31, 2023
Examining the Patterns of Mpox Vaccine Uptake in a Vulnerable PopulationRoy Zucker, Yael Wolff-Sagy, Noga Ramot, et al.
Harefuah|March 20, 2024
[IMPACT OF CLINICAL PHARMACIST CONSULTATIONS ON RATE OF COMPLICATIONS, RE-HOSPITALIZATIONS AND MORTALITY IN PATIENTS UNDERGOING BARIATRIC SURGERY]Almog Eliyahu Dahan, Arik Dahan, Orly Shimoni, et al.
Heart (British Cardiac Society)|April 12, 2019
Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillationRonen Arbel, Ruslan Sergienko, Ariel Hammerman, et al.
Pageof 6